What is the recommended dosage of nebivolol (beta blocker) for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nebivolol Dosing for Hypertension

For most patients with hypertension, start nebivolol at 5 mg once daily and titrate up to 40 mg daily if needed for blood pressure control, with dose increases at 2-week intervals. 1

Standard Dosing Regimen

  • Initial dose: 5 mg once daily (with or without food), as monotherapy or in combination with other antihypertensive agents 1
  • Titration schedule: Increase dose at 2-week intervals if further blood pressure reduction is required 1
  • Maximum dose: 40 mg once daily 1
  • More frequent dosing intervals are unlikely to provide additional benefit 1

Dose Adjustments for Special Populations

Severe Renal Impairment

  • Initial dose: 2.5 mg once daily for patients with creatinine clearance <30 mL/min 1
  • Titrate slowly as needed 1
  • Nebivolol has not been studied in dialysis patients 1

Moderate Hepatic Impairment

  • Initial dose: 2.5 mg once daily 1
  • Titrate slowly as needed 1
  • Not recommended in severe hepatic impairment due to lack of safety data 1

Elderly Patients

  • No dose adjustment necessary 1

CYP2D6 Poor Metabolizers

  • No dose adjustment required, as clinical effects and safety profiles are similar to extensive metabolizers 1

Clinical Efficacy Evidence

  • The 5 mg once daily dose reduces resting diastolic blood pressure as effectively as standard doses of atenolol, metoprolol, lisinopril, and nifedipine 2
  • Response rates (achieving diastolic BP ≤90 mmHg or ≥10 mmHg reduction) range from 58-81% after 4-52 weeks of treatment 2
  • In long-term studies, 78% of patients responded to nebivolol monotherapy, with 72% of patients maintained on monotherapy alone 3

Combination Therapy

  • Nebivolol has additive antihypertensive effects when combined with hydrochlorothiazide 2, 4
  • In long-term studies, 24% of patients required addition of a diuretic, with 65% of these combination patients achieving response 3

Dosing Equivalence to Other Beta-Blockers

  • Nebivolol 5 mg daily is equivalent to metoprolol 50 mg daily for hypertension management 5
  • Maximum dose of nebivolol (10 mg) for heart failure is equivalent to metoprolol succinate 200 mg 5

Safety and Tolerability

  • Adverse events are infrequent, transient, and mild to moderate 2
  • Most common adverse effects include headache, fatigue, paresthesias, and dizziness 2
  • No orthostatic hypotension reported in clinical studies 2
  • Overall adverse event incidence decreases over time with continued therapy 3

Important Clinical Considerations

  • Beta-blockers are not first-line agents for hypertension unless the patient has ischemic heart disease or heart failure 6
  • Nebivolol's unique nitric oxide-mediated vasodilatory properties distinguish it from other beta-blockers 2, 7
  • The drug does not significantly influence glucose or plasma lipid metabolism 2
  • Avoid abrupt discontinuation, which can lead to rebound hypertension or worsening cardiac symptoms 5

References

Guideline

Dosing Equivalence and Clinical Considerations for Nebivolol and Metoprolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Beta Blocker Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nebivolol: a new antihypertensive agent.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.